Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
29.09.23
/
50%
€11.70
Target price
29.09.24
€17.92
Performance (%)
-19.23%
End price
30.09.24
€9.45
Summary
This prediction ended on 30.09.24 with a price of €9.45. The price of Amicus Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.23%. JPMorgan_Chase___Co_ has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.65
06.11.25
06.11.25
€16.51
06.11.26
06.11.26
61.24%
27.04.26
27.04.26
Stopped prediction by JPMorgan_Chase___Co_ for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.85
12.11.24
12.11.24
€16.03
12.11.25
12.11.25
-18.27%
13.11.25
13.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.40
16.08.24
16.08.24
€14.55
16.08.25
16.08.25
-39.90%
17.08.25
17.08.25